Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
, Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health Last reviewed June 18, 2026 by Lauren Leavitt, M.D., Board-Certified Emergency Medicine Physician, Amanecia Health
USA 122 , e2517376122 (2025)
The combination of smaller sizes and altered orbital energies affect coordination preferences
Verma S, McMurray JJV
While an occasional protein shake is fine, replacing all meals with liquid calories often leads to blood sugar instability (liquid calories absorb faster) and inadequate satiety (chewing and the act of eating contribute to feeling satisfied)